US FDA issues labeling changes for testosterone products
The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products based on ...
JD Supra7d
FDA Guidance for Labeling Plant-based Products
The FDA has developed draft guidance addressing confusion and legal action over the naming and labeling of plant-based alternatives to eggs, ...
Medscape2d
Physicians Welcome Testosterone Labeling Changes
Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be ...
Becker's Hospital Review18d
FDA issues class-wide labeling changes to testosterone products to include blood pressure, cardiovascular warnings
The FDA has announced new labeling changes for all testosterone products following a review of clinical trial data, including a TRAVERSE study and postmarket ambulatory blood pressure studies.
Lipocine announces FDA labeling changes for testosterone products
Lipocine (LPCN) announced that the FDA has recently informed sponsors of approved testosterone products about class-wide labeling changes. This ...
Hosted on MSN20d
FDA issues labeling changes for testosterone products
(Reuters) - The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products. The FDA said it is recommending label changes based on results from a ...
Yahoo Finance8d
Lipocine Announces FDA Labeling Changes for Testosterone Products
"We are excited about these label changes, including the removal ... effective oral delivery to develop differentiated products. Lipocine has drug candidates in development as well as drug ...
The Victoria Advocate9d
Lipocine Announces FDA Labeling Changes for Testosterone Products
SALT LAKE CITY, March 12, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective ...